Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Bartley P. Griffith (born 1949) is an American heart surgeon. [2] Griffith joined Muhammad Mohiuddin's MD Xenoheart laboratory in 2018. Together, they were able to demonstrate that the heart of a genetically altered pig could support life when transplanted into an orthotopic position in the chest for up to 9 months.

  2. Bartley P. Griffith ( Pittsburgh, 1949) es un cirujano cardíaco estadounidense. 1 2 Griffith estudió en la Thomas Jefferson University en Filadelfia y obtuvo su título de Doctor en Medicina en 1974. Fue el médico que realizó el primer trasplante exitoso de un corazón de cerdo modificado genéticamente a un ser humano el 7 de enero de 2022.

  3. Dr. Griffith specializes in adult cardiac care, coronary revascularization, pulmonary thromboendarterectomy surgery (PTE) and heart reconstruction surgery. His clinical work focuses on coronary artery surgery, mitral and aortic valve replacement and aneurysmal disease of the thoracic aorta.

  4. Bartley P. Griffith, MD. Thomas E. and Alice Marie Hales Distinguished Professor of Transplant Surgery. Academic Title: Professor. Primary Appointment: Surgery. Administrative Title: Director of the Cardiac and Lung Transplant Programs; Vice Chair for Innovation. Additional Title: Founder of Breethe, Inc. Email: bgriffith@som.umaryland.edu.

  5. 22 de jun. de 2022 · Authors: Bartley P. Griffith, M.D., Corbin E. Goerlich, M.D., Ph.D. https://orcid.org/0000-0001-9691-5835, Avneesh K. Singh, Ph.D. https://orcid.org/0000-0002-8701-2260, Martine Rothblatt,...

  6. 22 de ene. de 2023 · SAN DIEGO (January 21, 2023) — Bartley P. Griffith, MD, a transformative surgeon in heart and lung transplantation and reconstruction—whose long career reached a pinnacle last year with the first porcine total heart transplant— was honored with the 2023 Earl Bakken Scientific Achievement Award from The Society of Thoracic ...

  7. 7 de jul. de 2022 · A 57-year-old man with nonischemic cardiomyopathy who was dependent on venoarterial extracorporeal membrane oxygenation (ECMO) and was not a candidate for standard therapeutics, including a traditional allograft, received a heart from a genetically modified pig source animal that had 10 individual g …